Return to our Home Page


Products
Product Spotlights
Calbiochem Product Spotlights
Biochemical Product Spotlights
Sonic Hedgehog Signaling: The Pattern Setter in Embryonic Development

Mammalian Hedgehog proteins include Sonic Hedgehog (Shh), Indian Hedgehog (Ihh), and Desert Hedgehog (Dhh). Shh is expressed mainly in the epithelia in the tooth, hair, whisker, gut, bladder, urethra, vas deferens, and lung, Dhh is found in Schwann and Sertoli cell precursors and Ihh is expressed in gut and cartilage. Hedgehog proteins undergo autocatalysis to generate a ~20 kDa N-terminal domain and a ~25 kDa C-terminal domain. This autoprocessing causes the covalent attachment of cholesterol onto the carboxy-terminus of the N-terminal domain. The N-terminal domain retains all signaling capabilities while the C-terminal domain is responsible for the intramolecular precursor processing. The cholesterol moiety is believed to be responsible for directing Hedgehog traffic in the secretory cell.

Shh, a secreted morphogen, has been implicated in several embryonic developmental processes. It displays inductive, proliferative, neurotrophic, and neuroprotective properties. Shh often works in concert with the Wnt signaling protein in setting embryonic patterns. The Wnt pathway uses b-catenin to transduce its signals to the nucleus; however, the Shh pathway utilizes a 155 amino acid protein, Cubitus interruptus (Ci155) in Drosophila or Gli in mammals. In the absence of a Shh signal, Ci is targeted for proteolysis, which generates a truncated 75-amino acid residues form (Ci75) that acts as a transcriptional repressor. In vertebrates t hree Gli proteins (Gli1, Gli2, and Gli3) have been reported. Despite several homologous regions, including a DNA-binding domain with five C2-H2 zinc fingers and a C-terminal transcription activation domain, these proteins have distinct activities and are not considered to be functionally equivalent.
Shh signaling is known to occur through a receptor complex associating two membrane proteins, Patched (Ptc) and Smoothened (Smo). Ptc is a twelve-pass membrane protein that acts as a receptor and binds Hedgehog ligand; Smo is a seven-pass membrane protein that acts as a signal transducer. In the absence of a ligand, Ptc interacts with Smo and inhibits its activity. Shh binding to Ptc removes the inhibitory effect and allows Gli to enter the nucleus and act as a transcriptional activator. Shh signaling is required throughout embryonic development and is involved in the determination of cell fate and embryonic patterning during early vertebrate development. During the late stage of development, Shh is involved in the proper formation of a variety of tissues and organs. Shh also functions with other signaling molecules such as the fibroblast growth factors and bone morphogenetic protein to mediate developmental processes. Mutations in any of the components of the Shh pathway can lead to congenital defects and diseases, including cancer. Hence, the Shh pathway has become a potential target for drug development for the treatment of cancers and degenerative diseases.

 
Product
Cat. No.
Description
AY 9944A cell-permeable amphiphilic diamine that blocks cholesterol biosynthesis and its esterification. Specifically blocks 7-dehydrocholesterol reductase (d7-sterol reductase) activity. Important tool in Sonic Hedgehog signaling and teratogenicity studies. Also reported to induce a rapid and irreversible reduction in Acidic-Sphingomyelinase activity in fibroblasts.
Cyclopamine, V. californicumA steroidal alkaloid and cholesterol mimic that displays both teratogenic and antitumor activities. It disrupts cholesterol bio-synthesis and specifically antagonizes shh (Sonic Hedgehog) signaling pathway through direct interaction with Smo (smoothened).
Cyclopamine-KAAD A potent analog of Cyclopamine (Cat. No. 239803) that specifically inhibits the Hedgehog (Hh) signaling with similar or lower toxicity (IC50 = 20 nM in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells). Binds to SmoA1 and promotes its exit from the endoplasmic reticulum. Suppresses both the ShhNp-induced pathway activity and SmoA1-induced reporter activity.
JervineA cell-permeable steroidal alkaloid similar to cyclopamine (Cat. No. 239803) that displays teratogenic effects and induces cyclopia by blocking shh (Sonic Hedgehog) signaling (IC50 ~ 500 - 700 nM in s12 cells). Tomatidine (Cat. No. 614350) serves as a suitable negative control.
Purmorphamine A cell-permeable 2,6,9-trisubstituted purine compound that induces osteoblast differentiation of multipotent mesenchymal progenitor cells C3H10T1/2 (EC50 = 1 mM) and lineage-committed preosteoblasts MC3T3-E1. Its effect can be synergized with that of BMP-4 (bone morphogenetic protein-4) and has been shown to induce transdifferentiation even in preadipocytes and myoblasts. Reported to induce osteogenesis by activation of the Hedgehog signaling pathway.
Tomatidine, HClA steroidal alkaloid that structurally resembles Cyclopamine (Cat. No. 239803), but lacks the capacity to inhibit shh (Sonic Hedgehog) signaling. Reported to be non-teratogenic.
SANT-1Acts as a potent antagonist of the Sonic Hedgehog (shh) signaling pathway (IC50 = 20 nM in the Shh-LIGHT2 assay and in Ptch1-l- cells) by binding directly to Smoothened (Smo; Kd = 1.2 nM), a distant relative of G protein-coupled receptors. Unlike cyclopamine, SANT-1 equipotently inhibits the activities of both wild type and oncogenic Smo (IC50 = 30 nM in SmoA1-LIGHT2 assay).
U18666AA cell-permeable, amphiphilic amino-steroid that alters intracellular membrane protein trafficking by impairing intracellular biosynthesis and transport of LDL-derived cholesterol, presumably via its inhibitory effect on 2,3-oxidosqualene-lanosterol cyclase activity. Also reported to inhibit the activity of d8-sterol isomerase.